1
|
Pagliari S, Dema B, Sanchez-Martinez A, Montalvo Zurbia-Flores G, Rollier CS. DNA Vaccines: History, Molecular Mechanisms and Future Perspectives. J Mol Biol 2023; 435:168297. [PMID: 37797831 DOI: 10.1016/j.jmb.2023.168297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Revised: 09/22/2023] [Accepted: 09/28/2023] [Indexed: 10/07/2023]
Abstract
The history of DNA vaccine began as early as the 1960s with the discovery that naked DNA can transfect mammalian cells in vivo. In 1992, the evidence that such transfection could lead to the generation of antigen-specific antibody responses was obtained and supported the development of this technology as a novel vaccine platform. The technology then attracted immense interest and high hopes in vaccinology, as evidence of high immunogenicity and protection against virulent challenges accumulated from several animal models for several diseases. In particular, the capacity to induce T-cell responses was unprecedented in non-live vaccines. However, the technology suffered its major knock when the success in animals failed to translate to humans, where DNA vaccine candidates were shown to be safe but remained poorly immunogenic, or not associated with clinical benefit. Thanks to a thorough exploration of the molecular mechanisms of action of these vaccines, an impressive range of approaches have been and are currently being explored to overcome this major challenge. Despite limited success so far in humans as compared with later genetic vaccine technologies such as viral vectors and mRNA, DNA vaccines are not yet optimised for human use and may still realise their potential.
Collapse
Affiliation(s)
- Sthefany Pagliari
- School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Barbara Dema
- Pandemic Science Institute, Institute of Developmental and Regenerative Medicine (IDRM), University of Oxford, Oxford, UK
| | | | | | - Christine S Rollier
- School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
| |
Collapse
|
2
|
Reinke S, Pantazi E, Chappell GR, Sanchez-Martinez A, Guyon R, Fergusson JR, Salman AM, Aktar A, Mukhopadhyay E, Ventura RA, Auderset F, Dubois PM, Collin N, Hill AVS, Bezbradica JS, Milicic A. Emulsion and liposome-based adjuvanted R21 vaccine formulations mediate protection against malaria through distinct immune mechanisms. Cell Rep Med 2023; 4:101245. [PMID: 37913775 PMCID: PMC10694591 DOI: 10.1016/j.xcrm.2023.101245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Revised: 08/07/2023] [Accepted: 09/22/2023] [Indexed: 11/03/2023]
Abstract
Adjuvanted protein vaccines offer high efficacy, yet most potent adjuvants remain proprietary. Several adjuvant compounds are being developed by the Vaccine Formulation Institute in Switzerland for global open access clinical use. In the context of the R21 malaria vaccine, in a mouse challenge model, we characterize the efficacy and mechanism of action of four Vaccine Formulation Institute adjuvants: two liposomal (LQ and LMQ) and two squalene emulsion-based adjuvants (SQ and SMQ), containing QS-21 saponin (Q) and optionally a synthetic TLR4 agonist (M). Two R21 vaccine formulations, R21/LMQ and R21/SQ, offer the highest protection (81%-100%), yet they trigger different innate sensing mechanisms in macrophages with LMQ, but not SQ, activating the NLRP3 inflammasome. The resulting in vivo adaptive responses have a different TH1/TH2 balance and engage divergent innate pathways while retaining high protective efficacy. We describe how modular changes in vaccine formulation allow for the dissection of the underlying immune pathways, enabling future mechanistically informed vaccine design.
Collapse
Affiliation(s)
- Sören Reinke
- The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK
| | - Eirini Pantazi
- Kennedy Institute of Rheumatology Research, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Medical Sciences Division, University of Oxford, Oxford OX3 7FY, UK
| | - Gabrielle R Chappell
- Kennedy Institute of Rheumatology Research, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Medical Sciences Division, University of Oxford, Oxford OX3 7FY, UK
| | | | - Romain Guyon
- The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK
| | - Joannah R Fergusson
- The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK
| | - Ahmed M Salman
- The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK
| | - Anjum Aktar
- Kennedy Institute of Rheumatology Research, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Medical Sciences Division, University of Oxford, Oxford OX3 7FY, UK
| | - Ekta Mukhopadhyay
- The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK
| | - Roland A Ventura
- Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-Les-Ouates, Switzerland
| | - Floriane Auderset
- Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-Les-Ouates, Switzerland
| | - Patrice M Dubois
- Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-Les-Ouates, Switzerland
| | - Nicolas Collin
- Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-Les-Ouates, Switzerland
| | - Adrian V S Hill
- The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK
| | - Jelena S Bezbradica
- Kennedy Institute of Rheumatology Research, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Medical Sciences Division, University of Oxford, Oxford OX3 7FY, UK.
| | - Anita Milicic
- The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
| |
Collapse
|
3
|
Navarro-López DE, Bautista-Ayala AR, Rosales-De la Cruz MF, Martínez-Beltrán S, Rojas-Torres DE, Sanchez-Martinez A, Ceballos-Sanchez O, Jáuregui-Jáuregui J, Lozano LM, Sepúlveda-Villegas M, Tiwari N, López-Mena ER. Nanocatalytic performance of pectinase immobilized over in situ prepared magnetic nanoparticles. Heliyon 2023; 9:e19021. [PMID: 37600413 PMCID: PMC10432700 DOI: 10.1016/j.heliyon.2023.e19021] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2023] [Revised: 08/04/2023] [Accepted: 08/07/2023] [Indexed: 08/22/2023] Open
Abstract
Immobilization of enzymes is one of the protein engineering methods used to improve their thermal and long-term stabilities. Immobilized pectinase has become an essential biocatalyst for optimization in the food processing industry. Herein, nanostructured magnetic nanoparticles were prepared in situ for use as supports to immobilize pectinase. The structural, morphological, optical and magnetic features and the chemical compositions of the nanoparticles were characterized. Nanoparticle agglomeration and low porosity were observed due to the synthetic conditions. These nanoparticles exhibited superparamagnetic behavior, which is desirable for biotechnological applications. The maximum retention rate for the enzyme was observed at pH 4.5 with a value of 1179.3 U/mgNP (units per milligram of nanoparticle), which was equivalent to a 65.6% efficiency. The free and immobilized pectinase were affected by the pH and temperature. The long-term instability caused 40% and 32% decreases in the specific activities of the free and immobilized pectinase, respectively. The effects of immobilization were analyzed with kinetic and thermodynamic studies. These results indicated a significant affinity for the substrate, a decreased reaction rate, and improved thermal stability of the immobilized pectinase. The reusability of the immobilized pectinase was preserved effectively during cycling, with only a 21.2% decrease in activity observed from the first to the last use. Therefore, alternative magnetic nanoparticles are presented for immobilizing and maintaining the thermostability of pectinase.
Collapse
Affiliation(s)
- Diego E. Navarro-López
- Tecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Av. Gral Ramón Corona No. 2514, Colonia Nuevo México, 45201, Zapopan, Jalisco, Mexico
| | - Alvaro R. Bautista-Ayala
- Tecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Av. Gral Ramón Corona No. 2514, Colonia Nuevo México, 45201, Zapopan, Jalisco, Mexico
| | - Maria Fernanda Rosales-De la Cruz
- Tecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Av. Gral Ramón Corona No. 2514, Colonia Nuevo México, 45201, Zapopan, Jalisco, Mexico
| | - Selina Martínez-Beltrán
- Tecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Av. Gral Ramón Corona No. 2514, Colonia Nuevo México, 45201, Zapopan, Jalisco, Mexico
| | - Diego E. Rojas-Torres
- Tecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Av. Gral Ramón Corona No. 2514, Colonia Nuevo México, 45201, Zapopan, Jalisco, Mexico
| | - A. Sanchez-Martinez
- CONACyT-Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Campus Siglo XXI, Carretera Zacatecas - Guadalajara Km 6, Ejido La Escondida, Zacatecas, 98160, Mexico
| | - O. Ceballos-Sanchez
- Universidad de Guadalajara, Centro Universitario de Ciencias Exactas e Ingenierias (CUCEI), Departamento de Ingenieria de Proyectos, Av. Jose Guadalupe Zuno #48, Industrial Los Belenes, Zapopan, Jalisco, 45157, Mexico
| | - J.A. Jáuregui-Jáuregui
- Tecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Av. Gral Ramón Corona No. 2514, Colonia Nuevo México, 45201, Zapopan, Jalisco, Mexico
| | - Luis Marcelo Lozano
- Tecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Av. Gral Ramón Corona No. 2514, Colonia Nuevo México, 45201, Zapopan, Jalisco, Mexico
| | - M. Sepúlveda-Villegas
- Departamento de Biología Molecular y Genómica, Hospital Civil de Guadalajara, “Fray Antonio Alcalde”, Guadalajara, 44280, Jalisco, Mexico
- Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, 44100, Jalisco, Mexico
| | - Naveen Tiwari
- Center for Research in Biological Chemistry and Molecular Materials (CiQUS), University of Santiago de Compostela, Rúa Jenaro de La Fuente S/N, 15782, Santiago de Compostela, A Coruna, Spain
| | - Edgar R. López-Mena
- Tecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Av. Gral Ramón Corona No. 2514, Colonia Nuevo México, 45201, Zapopan, Jalisco, Mexico
| |
Collapse
|
4
|
Navarro-López DE, Sánchez-Huerta TM, Flores-Jimenez MS, Tiwari N, Sanchez-Martinez A, Ceballos-Sanchez O, Garcia-Gonzalez A, Fuentes-Aguilar RQ, Sanchez-Ante G, Corona-Romero K, Rincón-Enríquez G, López-Mena ER. Nanocomposites based on doped ZnO nanoparticles for antibacterial applications. Colloids Surf A Physicochem Eng Asp 2022. [DOI: 10.1016/j.colsurfa.2022.129871] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
5
|
Navarro-López DE, Garcia-Varela R, Ceballos-Sanchez O, Sanchez-Martinez A, Sanchez-Ante G, Corona-Romero K, Buentello-Montoya DA, Elías-Zuñiga A, López-Mena ER. Effective antimicrobial activity of ZnO and Yb-doped ZnO nanoparticles against Staphylococcus aureus and Escherichia coli. Mater Sci Eng C Mater Biol Appl 2021; 123:112004. [PMID: 33812624 DOI: 10.1016/j.msec.2021.112004] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/27/2020] [Revised: 02/14/2021] [Accepted: 02/20/2021] [Indexed: 12/13/2022]
Abstract
Nanostructured Zn1-xYbxO (0.0 ≤ x ≤ 0.1) powders were prepared by the solution method using polyvinyl alcohol (PVA) and sucrose. The effect of the ytterbium doping content on the structural, morphological, optical and antimicrobial properties was analyzed. X-ray diffraction (XRD) analysis revealed that the hexagonal wurtzite structure was retained, and no secondary phases due to doping were observed. The crystallite size was under 20 nm for all the Zn1-xYbxO (0.0 ≤ x ≤ 0.1) powders. The optical band gap was calculated, and the results revealed that this value increased with the ytterbium content, and the Eg values varied from 3.06 to 3.10 eV. The surface chemistry of the powders was analyzed using X-ray photoelectron spectroscopy (XPS), and the results confirmed the oxidation state of ytterbium as 3+ for all the samples. Zn1-xYbxO (0.0 ≤ x ≤ 0.1) nanoparticles were tested as antimicrobial agents against Staphylococcus aureus and Escherichia coli, resulting in a potential antimicrobial effect at most of the tested concentrations. These results were used in an artificial neural network (ANN). The results showed that it is possible to generate a model capable of forecasting the absorbance with good precision (error of 1-2%).
Collapse
Affiliation(s)
- Diego Eloyr Navarro-López
- Tecnologico de Monterrey, Campus Guadalajara, Av. Gral Ramón Corona No 2514, Colonia Nuevo México, 45201 Zapopan, Jal, Mexico
| | - Rebeca Garcia-Varela
- Tecnologico de Monterrey, Campus Guadalajara, Av. Gral Ramón Corona No 2514, Colonia Nuevo México, 45201 Zapopan, Jal, Mexico
| | - O Ceballos-Sanchez
- Departamento de Ingeniería de Proyectos, CUCEI, Universidad de Guadalajara, Av. José Guadalupe Zuno # 48, Industrial los Belenes, Zapopan, Jalisco 45157, Mexico.
| | - A Sanchez-Martinez
- CONACYT-Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Campus Siglo XXI, Carretera Zacatecas - Guadalajara Km 6, Ejido La Escondida, 98160, Zacatecas, Zacatecas, Mexico
| | - Gildardo Sanchez-Ante
- Universidad Politecnica de Yucatan, Carretera Merida-Tetiz, Km. 4.5, Ucu, YUC 97357, Mexico
| | - Kaled Corona-Romero
- Tecnologico de Monterrey, Campus Guadalajara, Av. Gral Ramón Corona No 2514, Colonia Nuevo México, 45201 Zapopan, Jal, Mexico
| | - D A Buentello-Montoya
- Tecnologico de Monterrey, Campus Guadalajara, Av. Gral Ramón Corona No 2514, Colonia Nuevo México, 45201 Zapopan, Jal, Mexico
| | - Alex Elías-Zuñiga
- Tecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Campus Monterrey, Monterrey, Nuevo León 64849, Mexico
| | - Edgar R López-Mena
- Tecnologico de Monterrey, Campus Guadalajara, Av. Gral Ramón Corona No 2514, Colonia Nuevo México, 45201 Zapopan, Jal, Mexico.
| |
Collapse
|
6
|
Sanchez-Martinez A, Perdomo-Celis F, Acevedo-Saenz L, Rugeles MT, Velilla PA. Cytotoxic CD4 + T-cells during HIV infection: Targets or weapons? J Clin Virol 2019; 119:17-23. [PMID: 31445411 DOI: 10.1016/j.jcv.2019.08.004] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2019] [Revised: 07/16/2019] [Accepted: 08/13/2019] [Indexed: 12/23/2022]
Abstract
Classically, CD4+ T-cells have been referred as cytokine-producing cells and important players in immune responses by providing soluble factors that potentiate several effector immune functions. However, it is now evident that CD4+ T-cells can also elaborate cytotoxic responses, inducing apoptosis of target cells. Cytotoxic CD4+ T cells (CD4+ CTLs), exhibit cytolytic functions that resemble those of CD8+ T-cells; in fact, there is evidence suggesting that they may have a role in the control of viral infections. In this article, we discuss the role of CD4+ CTLs during HIV infection, where CD4+ CTLs have been associated with viral control and slow disease progression. In addition, we address the implication of CD4+ CTLs in the context of antiretroviral therapy and the partial reconstitution of CD8+ T-cells effector function.
Collapse
Affiliation(s)
| | - Federico Perdomo-Celis
- Grupo Inmunovirologia, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia
| | - Liliana Acevedo-Saenz
- Grupo Inmunovirologia, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia; Grupo de Investigación Enfermería-CES, Facultad de Enfermería, Universidad CES, Medellin, Colombia
| | - Maria T Rugeles
- Grupo Inmunovirologia, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia
| | - Paula A Velilla
- Grupo Inmunovirologia, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia.
| |
Collapse
|